372 related articles for article (PubMed ID: 15842509)
1. Prognostic value of the Framingham cardiovascular risk equation and the UKPDS risk engine for coronary heart disease in newly diagnosed Type 2 diabetes: results from a United Kingdom study.
Guzder RN; Gatling W; Mullee MA; Mehta RL; Byrne CD
Diabet Med; 2005 May; 22(5):554-62. PubMed ID: 15842509
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the Framingham and United Kingdom Prospective Diabetes Study cardiovascular risk equations in Australian patients with type 2 diabetes from the Fremantle Diabetes Study.
Davis WA; Colagiuri S; Davis TM
Med J Aust; 2009 Feb; 190(4):180-4. PubMed ID: 19220181
[TBL] [Abstract][Full Text] [Related]
3. Comparison of three different methods of assessing cardiovascular disease risk in New Zealanders with Type 2 diabetes mellitus.
Metcalf PA; Wells S; Scragg RK; Jackson R
N Z Med J; 2008 Sep; 121(1281):49-57. PubMed ID: 18797484
[TBL] [Abstract][Full Text] [Related]
4. Assessing 10-Year Cardiovascular Disease Risk in Malaysians With Type 2 Diabetes Mellitus: Framingham Cardiovascular Versus United Kingdom Prospective Diabetes Study Equations.
Yew SQ; Chia YC; Theodorakis M
Asia Pac J Public Health; 2019 Oct; 31(7):622-632. PubMed ID: 31535566
[TBL] [Abstract][Full Text] [Related]
5. Deficiencies of cardiovascular risk prediction models for type 1 diabetes.
Zgibor JC; Piatt GA; Ruppert K; Orchard TJ; Roberts MS
Diabetes Care; 2006 Aug; 29(8):1860-5. PubMed ID: 16873793
[TBL] [Abstract][Full Text] [Related]
6. Recalculation of cardiovascular risk score as a surrogate marker of change in clinical care of diabetes patients: the Alphabet POEM project (Practice Of Evidence-based Medicine).
Lee JD; Morrissey JR; Patel V;
Curr Med Res Opin; 2004 May; 20(5):765-72. PubMed ID: 15140344
[TBL] [Abstract][Full Text] [Related]
7. External validation of the UK Prospective Diabetes Study (UKPDS) risk engine in patients with type 2 diabetes.
van Dieren S; Peelen LM; Nöthlings U; van der Schouw YT; Rutten GE; Spijkerman AM; van der A DL; Sluik D; Boeing H; Moons KG; Beulens JW
Diabetologia; 2011 Feb; 54(2):264-70. PubMed ID: 21076956
[TBL] [Abstract][Full Text] [Related]
8. Coronary heart disease risk assessment in diabetes mellitus: comparison of UKPDS risk engine with Framingham risk assessment function and its clinical implications.
Song SH; Brown PM
Diabet Med; 2004 Mar; 21(3):238-45. PubMed ID: 15008833
[TBL] [Abstract][Full Text] [Related]
9. External validation of the UK prospective diabetes study (UKPDS) risk engine in patients with type 2 diabetes identified in the national diabetes program in Iran.
Valipour M; Khalili D; Solaymani-Dodaran M; Motevalian SA; Khamseh ME; Baradaran HR
J Diabetes Metab Disord; 2023 Dec; 22(2):1145-1150. PubMed ID: 37975087
[TBL] [Abstract][Full Text] [Related]
10. Development of a prediction model for fatal and non-fatal coronary heart disease and cardiovascular disease in patients with newly diagnosed type 2 diabetes mellitus: the Basque Country Prospective Complications and Mortality Study risk engine (BASCORE).
Piniés JA; González-Carril F; Arteagoitia JM; Irigoien I; Altzibar JM; Rodriguez-Murua JL; Echevarriarteun L;
Diabetologia; 2014 Nov; 57(11):2324-33. PubMed ID: 25212259
[TBL] [Abstract][Full Text] [Related]
11. Prediction of 10-year coronary heart disease risk in Caribbean type 2 diabetic patients using the UKPDS risk engine.
Ezenwaka CE; Nwagbara E; Seales D; Okali F; Hussaini S; Raja B; Jones-LeCointe A; Sell H; Avci H; Eckel J
Int J Cardiol; 2009 Mar; 132(3):348-53. PubMed ID: 18191239
[TBL] [Abstract][Full Text] [Related]
12. Evaluating the performance of the Framingham risk equations in a population with diabetes.
McEwan P; Williams JE; Griffiths JD; Bagust A; Peters JR; Hopkinson P; Currie CJ
Diabet Med; 2004 Apr; 21(4):318-23. PubMed ID: 15049932
[TBL] [Abstract][Full Text] [Related]
13. Prediction of coronary heart disease risk in a general, pre-diabetic, and diabetic population during 10 years of follow-up: accuracy of the Framingham, SCORE, and UKPDS risk functions: The Hoorn Study.
van der Heijden AA; Ortegon MM; Niessen LW; Nijpels G; Dekker JM
Diabetes Care; 2009 Nov; 32(11):2094-8. PubMed ID: 19875606
[TBL] [Abstract][Full Text] [Related]
14. Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.
Whitfield MD; Gillett M; Holmes M; Ogden E
Public Health; 2006 Dec; 120(12):1140-8. PubMed ID: 17084425
[TBL] [Abstract][Full Text] [Related]
15. Impact of UKPDS risk estimation added to a first subjective risk estimation on management of coronary disease risk in type 2 diabetes - An observational study.
Wind AE; Gorter KJ; van den Donk M; Rutten GE
Prim Care Diabetes; 2016 Feb; 10(1):27-35. PubMed ID: 25997631
[TBL] [Abstract][Full Text] [Related]
16. External validation of the UKPDS risk engine in incident type 2 diabetes: a need for new type 2 diabetes-specific risk equations.
Bannister CA; Poole CD; Jenkins-Jones S; Morgan CL; Elwyn G; Spasic I; Currie CJ
Diabetes Care; 2014 Feb; 37(2):537-45. PubMed ID: 24089541
[TBL] [Abstract][Full Text] [Related]
17. Agreement between Framingham Risk Score and United Kingdom Prospective Diabetes Study Risk Engine in Identifying High Coronary Heart Disease Risk in North Indian Population.
Bansal D; Nayakallu RS; Gudala K; Vyamasuni R; Bhansali A
Diabetes Metab J; 2015 Aug; 39(4):321-7. PubMed ID: 26301194
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular risk and diabetes. Are the methods of risk prediction satisfactory?
Stephens JW; Ambler G; Vallance P; Betteridge DJ; Humphries SE; Hurel SJ
Eur J Cardiovasc Prev Rehabil; 2004 Dec; 11(6):521-8. PubMed ID: 15580065
[TBL] [Abstract][Full Text] [Related]
19. Impact of using a non-diabetes-specific risk calculator on eligibility for statin therapy in type 2 diabetes.
Price HC; Coleman RL; Stevens RJ; Holman RR
Diabetologia; 2009 Mar; 52(3):394-7. PubMed ID: 19048226
[TBL] [Abstract][Full Text] [Related]
20. Comparative accuracy of cardiovascular risk prediction methods in patients with diabetes mellitus.
Game FL; Bartlett WA; Bayly GR; Jones AF
Diabetes Obes Metab; 2001 Aug; 3(4):279-86. PubMed ID: 11520308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
